STAT News

What are the potential impacts of the FDA's review on access to abortion pills in Louisiana?

A federal district court on Tuesday paused Louisiana’s lawsuit against the Food and Drug Administration’s liberalization of dispensing rules for the abortion pill mifepristone until the agency is able to complete a safety review, intensifying the conflict between anti-abortion Republicans and the Trump administration. Judge David Joseph of the Western District of Louisiana, who was […]

How should we decide which new drugs get approved for rare diseases?

In today's Readout Newsletter, Denali and Corcept win FDA approvals, Sarepta eyes a rebound, and Allogene progresses with an off-the-shelf CAR-T

How should we balance the risks and benefits of using AI in healthcare?

In this edition of STAT Health Tech: An AI chatbot for surgical patients got 'breakthrough' status from FDA, HHS phases out Claude, and more

How could the use of obesity drugs like GLP-1 impact addiction rates in communities?

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% fewer drug-related hospitalizations

What different ideas could help improve the national response to addiction?

President Donald Trump took executive action on Thursday to create the White House Great American Recovery Initiative in order to better coordinate the country’s national response to addiction. “Many of those with me today have personally known the heartache of a loved one taken by drug or alcohol addiction,” Trump told reporters in the Oval […]

What are the pros and cons of making more medications available over the counter?

FDA Commissioner Marty Makary said he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring

What do you think are the reasons behind the rise in life expectancy in the U.S., and what does it mean for our communities?